Domestic Sputnik V CMO meets with MOHW for discussions
By Kim, Jin-Gu | translator Alice Kang
21.04.18 15:44:32
°¡³ª´Ù¶ó
0
"To confirm production volume, schedule, etc. with vaccine procurement task force¡¦ further meetings yet unscheduled
Negotiations with the Russian Direct Investment Fund (RDIF) and approval from MFDS required for domestic use
¡ãPhoto of Sputnik V
With the possibility of using ¡®Sputnik V' rising in Korea, various industry sources have confirmed that a Korean CMO of this Russian vaccine has had a meeting with Korea's Ministry of Health and Welfare (MOHW).
According to industry officials, one of the companies that signed a CMO deal for Sputnik V has recently had a meeting with an official from the Vaccine Procurement Task Force at the MOHW Sejong Office.
The meeting was held at the request of the MOHW, during which the CMO company briefly explained its production volume, schedule, and agreement process for Sputnik V. Future meetings between the company and MOHW have not been scheduled yet.
An industry offic
Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)